Novogaia

Novogaia develops new medicines from fungi using AI. According to its website, it characterizes new fungal chemical space and maps it to biologically and commercially de-risked targets in areas of unmet need. Its machine learning systems decode drug-like molecular structures from natural samples, and the company introduced its Gaia-01 system in an October 27, 2025 post.

The website does not name customers, partners or a revenue model. It presents the company as developing its own medicines. The site footer reads "Novogaia Inc." and the registry lists the company in the United Kingdom (GB).

The website states that the company is hiring and lists one open role, ML Research Engineer, based in London. No founding year, headquarters address, funding or team size is given on the website.

Product: Gaia-01, a machine learning system for decoding drug-like molecular structures from natural fungal samples.